Tag:

Parkinson's

Latest Headlines

Latest Headlines

Cedars-Sinai researchers find Parkinson's disease wearable tracker useful to tailor treatment

The FDA approved the Personal KinetiGraph in late 2014. The wrist-worn device tracks the movements of Parkinson's disease patients every two minutes over anywhere from 6 to 10 days.

Open-science nonprofit trots out promising data from study of iPhone app for Parkinson's

Open-science nonprofit Sage Bionetworks has released promising data from a study of its iPhone app for Parkinson's. The news is a feather in the organization's cap as it forges ahead with its technology and fleshes out the system to help researchers develop better insights into the disease.

Imperial team targets a key culprit involved in Parkinson's

One of the last measures of defense used against Parkinson's is deep brain stimulation aimed at amping up nerve cells in the brain. But the treatment method is imprecise and has an erratic and often limited impact on patients. Now researchers say they were able to target a particular set of brain cells with a new therapy that demonstrated real promise for eventually treating Parkinson's.

NYU Langone team spotlights new antibodies for Alzheimer's, Parkinson's

With the Alzheimer's Association International Conference underway in Washington, DC, there's been a big focus on the late-stage pipeline. But scientists at NYU Langone Medical Center were focused on new animal data that they say supports work on a new group of antibodies that can tackle two of the chief culprits behind the brain-damaging disease.

Medtronic touts the first neurostimulator to get approval for use during full-body MRI scan

European patients using certain models of Medtronic's Activa line of Deep Brain Stimulation Therapy neurostimulators can receive a full-body MRI scan while continuing to receive therapy, the company announced.

Skin test could vastly simplify diagnosis of Alzheimer's and Parkinson's

Researchers have discovered that a skin sample taken from behind the ear of patients with either Alzheimer's or Parkinson's disease had levels of the protein tau 7 times higher than those without the condition. Those with Parkinson's showed levels of alpha-synuclein protein that were 8 times higher than those in the control group.

Skin test could vastly simplify diagnosis of Alzheimer's and Parkinson's

Researchers have discovered that a skin sample taken from behind the ear of patients with either Alzheimer's or Parkinson's disease had levels of the protein tau 7 times higher than those without the condition. Those with Parkinson's showed levels of alpha-synuclein protein that were 8 times higher than those in the control group.

Device for remote, autonomous Parkinson's management being tested in Europe

Portuguese researchers are developing and testing a smart, portable system to manage Parkinson's disease in real time. The so-called Rempark system has been tested on more than 50 volunteers from Spain, Italy, Ireland and Israel, reports Medical Xpress. Unlike previous studies, these outpatients lived at home and used the device in real-world conditions.

Scripps investigators refine new drugs for Parkinson's disease

The Florida branch of The Scripps Research Institute is touting some new advances related to Parkinson's disease. Researchers say they have been working on new therapies that can precisely hit pathways critical for the death of brain cells, a hallmark of the disease. And they're now fine tuning their work by focusing on the oral bioavailability of their new drug candidates.

FDA approves AbbVie's Parkinson's drug, featuring delivery straight into the GI tract

The FDA just approved AbbVie's novel formulation of the standard Parkinson's drugs carbidopa and levodopa, Duopa, which is delivered straight into the patient's small intestine over 16 consecutive hours using an infusion pump and procedurally placed tube.